Net profit of DCM Shriram declined 19.09% to Rs 212.11 crore in the quarter ended December 2025 as against Rs 262.14 crore during the previous quarter ended December 2024. Sales rose 13.01% to Rs 3785.63 crore in the quarter ended December 2025 as against Rs 3349.95 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3785.633349.95 13 OPM %14.0414.81 - PBDT511.48494.31 3 PBT377.49385.52 -2 NP212.11262.14 -19 Powered by Capital Market - Live News

DCM Shriram announced that the Board of Directors of the Company at its meeting held on 20 January 2026, has recommended a Second Interim Dividend of Rs.3.60 per share (i.e.180%), subject to the approval of the shareholders.Powered by Capital Market - Live News

DCM Shriram will hold a meeting of the Board of Directors of the Company on 20 January 2026.Powered by Capital Market - Live News

 DCM Shriram and Bayer Cropscience today signed a Memorandum of Understanding (MoU) to jointly explore opportunities that strengthen India`s agriculture ecosystem through innovation, sustainability, and farmer-centric solutions. The MoU establishes a strategic framework for collaboration across areas such as agri-inputs, digital advisory, sustainable farming practices, and value-chain strengthening. Under this collaboration, both organizations will explore synergies in crop solutions, seeds, specialty plant nutrition, biologicals, digital tools and advisory platforms. The two companies will also assess opportunities to jointly support farmer organisations and strengthen sustainable agriculture initiatives, including pilots in soil health, carbon sequestration, and integrated crop management. Additionally, both companies will evaluate possibilities for partnership across select areas of the chemicals business. Powered by Capital Market - Live News

DCM Shriram announced that Dr. Paresh Verma, Executive Director & Research Director - Bioseed Research Business of the Company, will retire from the services of the Company with effect from closing of business hours of 31 October 2025, after leading this business for over 23 years. Consequently, Dr. Verma will also cease to be Senior Management Personnel (SMP) with effect from the said date. Powered by Capital Market - Live News